Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry

NCT06868459 is registered in ClinicalTrials.gov with Sarasota Memorial Health Care System as lead sponsor.

NCT NCT06868459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06868459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry
Lead sponsor
Sarasota Memorial Health Care System
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 1, 2025
Completion date
April 1, 2028
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hyperthyroidism, hyperthyroidism; goiter, multinodular goiter, thyroid disease, thyroid nodules, toxic multinodular goiter